Life at EMD Millipore is about making life science research, development, and production faster, easier, and more effective. The company is a US-based subsidiary and one of four main divisions of Germany's Merck KGaA. Outside of North America, it is known as the Merck Millipore division. The company is a top tier supplier of a comprehensive set of products and services primarily to pharma, biotech, and academic markets worldwide. Its product portfolio includes active pharmaceutical ingredients, drug delivery compounds, chemicals and reagents, and instrumentation. Among EMD Millipore's services are contract manufacturing, custom packaging, testing, consulting, and maintenance.
Headquartered in Massachusetts, EMD Millipore has locations throughout the Americas, Europe, and Asia/Pacific.
Parent Merck's business is divided into two main sectors: Pharmaceuticals and Chemicals. Divisions Merck Serono and Consumer Health Care (mainly OTC pharmaceuticals) make up Merck's Pharmaceuticals business sector, while Performance Materials and EMD Millipore (including its three business units Bioscience, Lab Solutions, and Process Solutions) comprise Merck's Chemicals business sector. EMD Millipore (or Merck Millipore as it is also known) is parent Merck's second-largest division by revenues behind Merck Serono.
EMD Millipore's Bioscience unit delivers products and technologies that improve laboratory productivity and work flows for life science research. The Lab Solutions unit supplies products for research, analytical and clinical laboratories, while Process Solutions helps pharma and biotech companies develop and/or improve their drug manufacturing processes.
Sales and Marketing
EMD Millipore's main customer base includes pharmaceutical and biotechnology companies, as well as academic research institutions. Certain lab-related products and services are geared at the food and beverage and personal care (cosmetics) industries, which require a significant degree of testing due to consumer regulatory requirements.
EMD Millipore was established after Merck acquired leading life science company Millipore Corporation for a whopping €5.2 billion ($7 billion) in mid-2010. Merck subsequently folded its EMD Chemicals (or Merck Chemicals) business into EMD Millipore to create a top three player in the life sciences industry, with enhanced global manufacturing, sales, and distribution capabilities and a comprehensive range of products, technologies, and services for pharma and biotech companies and university labs. The Millipore acquisition also resulted in a better balance between Merck's Pharmaceuticals and Chemicals business sectors in fiscal 2011.
EMD Millipore's revenues increased by 48% in fiscal 2011 largely thanks to the 2010 Millipore acquisition. As far as more mature markets, sales growth for EMD Millipore is particularly good in Europe. In terms of emerging markets, EMD Millipore accounts for more than half of Merck's sales in India and nearly one-quarter of Merck's sales in China, two markets where it will likely continue to pursue growth.
Mergers and Acquisitions
In Europe, EMD Millipore strengthened its biomonitoring business -- focused on microbiological testing -- in 2011 when it acquired the microbiology business of Germany's Biotest AG for €50 million ($70 million). EMD Millipore's biomonitoring portfolio consists of testing products that analyze the presence of microbial contaminants. Such testing products are widely used by food and beverage, personal care, pharmaceutical, and water treatment industries.
Also in 2011 EMD Millipore acquired Seattle-based Amnis Corporation, a maker of high-speed cell imaging instrumentation used in academic, biotech, and pharmaceutical cell analysis and research. Terms of the deal were not disclosed, but Amnis' technology complements EMD Millipore's Guava flow cytometry products and may allow it address several unmet needs in the field of cell analysis. – less